Latest round

Series E

Last raised

Sep 2009

Total raised

$65M

Investors

6

About Agendia

Agendia, Inc.Founded in 2003 and headquartered in Irvine, US, Agendia, Inc. specializes in genomic testing for breast cancer. The founder, Rene Bernards, has a background in developing diagnostic solutions prior to Agendia.Agendia offers genomic testing solutions, primarily through its products MammaPrint and BluePrint. These tests are designed to evaluate the genomic characteristics of tumors to predict breast cancer recurrence and identify molecular subtypes. The insights provided by these tests facilitate the creation of tailored treatment strategies that help avoid both under-treatment and over-treatment in patients.S. and international markets. The company aims to establish new collaborative research programs to enhance its product offerings and increase market penetration. Agendia is focused on releasing new products to strengthen its portfolio and meet the rising demand for precision genomic insights in breast cancer management.

Who invested in Agendia

6 investors across 5 rounds

See all investors in Agendia

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series E

    Sep 23, 2009

    Amount

    $23M

    Investors

    Locked

  2. Series D

    Aug 28, 2007

    Amount

    $36M

    Investors

    Locked

  3. Series C

    Jun 2, 2006

    Amount

    Undisclosed

    Investors

    Locked

  4. Series B

    Oct 11, 2005

    Amount

    Undisclosed

    Investors

    Locked

  5. Series A

    Mar 30, 2004

    Amount

    $6.1M

    Investors

    Locked

Questions about Agendia

Who invested in Agendia?

Agendia has 6 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Agendia raised?

Agendia has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Agendia last raise money?

Agendia's most recent round on record is a Series E, in Sep 2009.

What does Agendia do?

Agendia is a biotechnology company.

Where is Agendia headquartered?

Agendia is headquartered in Irvine, US.

Which VCs invest in companies like Agendia?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Agendia's stage. Their profiles are linked below.

Raising like Agendia? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.